Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7758101 | 0.85 | CYP4F2 (0.42) | CYP4F2CYP4A11THRBPKM | |
| SCHEMBL703499 | 0.81 | CYP4F2 (0.39) | CYP4F2CYP4A11ALDH1A1THRBPKM | |
| SCHEMBL10837533 | 0.79 | CYP4F2 (0.40) | CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL703088 | 0.78 | CYP4F2 (0.46) | CYP4F2CYP4A11ALDH1A1THRBPKM | |
| SCHEMBL2065097 | 0.78 | CYP4F2 (0.46) | CYP4F2CYP4A11 | |
| SCHEMBL2477744 | 0.77 | CYP4F2 (0.39) | CYP4F2CYP4A11ALDH1A1THRBPKM | |
| SCHEMBL11475136 | 0.74 | CYP4F2 (0.38) | CYP4F2CYP4A11 | |
| SCHEMBL7059566 | 0.74 | CYP4F2 (0.33) | CYP4F2CYP4A11 | |
| SCHEMBL2371362 | 0.74 | CYP4F2 (0.38) | CYP4F2CYP4A11 | |
| SCHEMBL11021508 | 0.74 | CYP4F2 (0.38) | CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148446-B2 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SIGMAKALON B.V. (NL) | 2012-04-03 | — | — | US | claimed |
| US-8039049-B2 | Treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2011-10-18 | — | — | US | claimed |
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | GILLARD MICHEL | 2010-09-30 | — | — | US | claimed |
| US-7405168-B2 | Plural treatment step process for treating dielectric films | TOKYO ELECTRON LIMITED (JP) | 2008-07-29 | — | — | US | claimed |
| US-20080076262-A1 | METHOD AND SYSTEM FOR TREATING A DIELECTRIC FILM | TOKYO ELECTRON LIMITED (JP) | 2008-03-27 | — | — | US | claimed |
| US-7345000-B2 | Method and system for treating a dielectric film | TOKYO ELECTRON LIMITED (JP) | 2008-03-18 | — | — | US | claimed |
| US-20070087025-A1 | Reiteratively layered medical devices and method of preparing same | FITZHUGH ANTHONY | 2007-04-19 | — | — | US | claimed |
| WO-2007040834-A2 | PLURAL TREATMENT STEP PROCESS FOR TREATING DIELECTRIC FILMS | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| WO-2007040816-A2 | TREATMENT OF LOW DIELECTRIC CONSTANT FILMS USING A BATCH PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| WO-2007040856-A2 | PLASMA-ASSISTED VAPOR PHASE TREATMENT OF LOW DIELECTRIC CONSTANT FILMS USING A BATCH PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| US-20070077782-A1 | Treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2007-04-05 | — | — | US | claimed |
| WO-2006091264-A1 | METHOD AND SYSTEM FOR TREATING A DIELECTRIC FILM | TOKYO ELECTRON LIMITED (JP) | 2006-08-31 | — | — | WO | claimed |
| US-20050215072-A1 | Method and system for treating a dielectric film | TOKYO ELECTRON LIMITED (JP) | 2005-09-29 | — | — | US | claimed |
| EP-1436018-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2004-07-14 | — | — | EP | claimed |
| EP-1432857-A1 | COATED OPTICAL FIBERS USING ADHESION PROMOTERS, AND METHODS FOR MAKING AND USING SAME | BORDEN CHEMICAL, INC. (US) | 2004-06-30 | — | — | EP | claimed |
| US-20030129397-A1 | Coated optical fibers using adhesion promoters, and methods for making and using same | HEXION INC. | 2003-07-10 | — | — | US | claimed |
| WO-2003026717-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-04-03 | — | — | WO | claimed |
| WO-2003023101-A1 | COATED OPTICAL FIBERS USING ADHESION PROMOTERS, AND METHODS FOR MAKING AND USING SAME | BORDEN CHEMICAL, INC. (US) | 2003-03-20 | — | — | WO | claimed |
| US-4135045-A | PROCESS FOR POLYMERIZATION OF OLEFINS AND CATALYST COMPOSITION THEREFOR | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-01-16 | — | — | US | claimed |
| US-4048415-A | TITANIUM-ALUMINUM COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1977-09-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070087025-A1 | Reiteratively layered medical devices and method of preparing same | NOS2, NOS1, NOS3 | CYP4F2 997/4885CYP4A11 199/4885ALDH1A1 2127/4885 |
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | LCT, PCMT1, TST | CYP4F2 1316/4885CYP4A11 672/4885ALDH1A1 2426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.